ELAC2 and cancer: Similarly, some progressors (CHMP4B, CSTF1, and LSM14B) and suppressors RBPs (ATP5F1A, GTF2E2, RTF1, ELAC2, LRRC47, and MRM3) have never been associated with COAD or READ, but present oncogenic properties in other cancer types (Table 1, Supplementary Tables S2, S3).